BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19349106)

  • 1. Thermodynamic approach to oxygen delivery in vivo by natural and artificial oxygen carriers.
    Bucci E
    Biophys Chem; 2009 Jun; 142(1-3):1-6. PubMed ID: 19349106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Numerical simulation of oxygen delivery to muscle tissue in the presence of hemoglobin-based oxygen carriers.
    Patton JN; Palmer AF
    Biotechnol Prog; 2006; 22(4):1025-49. PubMed ID: 16889379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy.
    Gundersen SI; Palmer AF
    Biotechnol Prog; 2008; 24(6):1353-64. PubMed ID: 19194950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acellular invertebrate hemoglobins as model therapeutic oxygen carriers: unique redox potentials.
    Harrington JP; Kobayashi S; Dorman SC; Zito SL; Hirsch RE
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):53-67. PubMed ID: 17364471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes.
    Olson JS; Foley EW; Rogge C; Tsai AL; Doyle MP; Lemon DD
    Free Radic Biol Med; 2004 Mar; 36(6):685-97. PubMed ID: 14990349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted oxygen delivery within hepatic hollow fiber bioreactors via supplementation of hemoglobin-based oxygen carriers.
    Sullivan JP; Palmer AF
    Biotechnol Prog; 2006; 22(5):1374-87. PubMed ID: 17022677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of recombinant hemoglobins for use in transfusion fluids.
    Fronticelli C; Koehler RC
    Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast screening method for the detection of the abuse of hemoglobin-based oxygen carriers (HBOCs) in doping control.
    Donati F; Botrè F
    Talanta; 2010 Apr; 81(1-2):252-4. PubMed ID: 20188917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox concerns in the use of acellular hemoglobin-based therapeutic oxygen carriers: the role of plasma components.
    Harrington JP; Gonzalez Y; Hirsch RE
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Nov; 28(6):477-92. PubMed ID: 11063090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
    Eastman AL; Minei JP
    Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red cell substitutes.
    Winslow RM
    Semin Hematol; 2007 Jan; 44(1):51-9. PubMed ID: 17198847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hemoglobin concentration and affinity for oxygen on tissue oxygenation: the case of hemoglobin-based oxygen carriers.
    Samaja M; Terraneo L
    Artif Organs; 2012 Feb; 36(2):210-5. PubMed ID: 21848930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential uses of hemoglobin-based oxygen carriers in critical care medicine.
    Creteur J; Vincent JL
    Crit Care Clin; 2009 Apr; 25(2):311-24, Table of Contents. PubMed ID: 19341911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoglobin-enhanced oxygen delivery to isolated cardiac mitochondria.
    Wittenberg JB; Wittenberg BA
    J Exp Biol; 2007 Jun; 210(Pt 12):2082-90. PubMed ID: 17562881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thermodynamic analysis of saturation degree of O2 in myoglobin and hemoglobin].
    Wu QC; Wang XM
    Space Med Med Eng (Beijing); 1999 Aug; 12(4):298-302. PubMed ID: 11542716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation promotes hemoglobin tetramer dissociation.
    Caccia D; Ronda L; Frassi R; Perrella M; Del Favero E; Bruno S; Pioselli B; Abbruzzetti S; Viappiani C; Mozzarelli A
    Bioconjug Chem; 2009 Jul; 20(7):1356-66. PubMed ID: 19534518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic science offers a challenge for developing hemoglobin based oxygen carriers into therapeutic agents.
    Bucci E
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Aug; 39(4):206-13. PubMed ID: 21692690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant hemoglobins as artificial oxygen carriers.
    Fronticelli C; Koehler RC; Brinigar WS
    Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(1):45-52. PubMed ID: 17364470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.